Beta Bionics, Common Stock Market Value
| BBNX Stock | 31.86 0.77 2.48% |
| Symbol | Beta |
Beta Bionics, Common Price To Book Ratio
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Beta Bionics,. If investors know Beta will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Beta Bionics, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.94) | Revenue Per Share | Quarterly Revenue Growth 0.631 | Return On Assets | Return On Equity |
The market value of Beta Bionics, Common is measured differently than its book value, which is the value of Beta that is recorded on the company's balance sheet. Investors also form their own opinion of Beta Bionics,'s value that differs from its market value or its book value, called intrinsic value, which is Beta Bionics,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Beta Bionics,'s market value can be influenced by many factors that don't directly affect Beta Bionics,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Beta Bionics,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Beta Bionics, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Beta Bionics,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Beta Bionics, 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Beta Bionics,'s stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Beta Bionics,.
| 07/01/2025 |
| 12/28/2025 |
If you would invest 0.00 in Beta Bionics, on July 1, 2025 and sell it all today you would earn a total of 0.00 from holding Beta Bionics, Common or generate 0.0% return on investment in Beta Bionics, over 180 days. Beta Bionics, is related to or competes with STAAR Surgical, Pulse Biosciences, Terns Pharmaceuticals, Precigen, Immatics, Kestra Medical, and Dynavax Technologies. Beta Bionics, is entity of United States More
Beta Bionics, Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Beta Bionics,'s stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Beta Bionics, Common upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.92 | |||
| Information Ratio | 0.1206 | |||
| Maximum Drawdown | 20.18 | |||
| Value At Risk | (5.66) | |||
| Potential Upside | 8.64 |
Beta Bionics, Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Beta Bionics,'s investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Beta Bionics,'s standard deviation. In reality, there are many statistical measures that can use Beta Bionics, historical prices to predict the future Beta Bionics,'s volatility.| Risk Adjusted Performance | 0.1069 | |||
| Jensen Alpha | 0.4277 | |||
| Total Risk Alpha | 0.1325 | |||
| Sortino Ratio | 0.1318 | |||
| Treynor Ratio | 0.2706 |
Beta Bionics, Common Backtested Returns
Beta Bionics, appears to be not too volatile, given 3 months investment horizon. Beta Bionics, Common secures Sharpe Ratio (or Efficiency) of 0.2, which signifies that the company had a 0.2 % return per unit of risk over the last 3 months. By analyzing Beta Bionics,'s technical indicators, you can evaluate if the expected return of 0.82% is justified by implied risk. Please makes use of Beta Bionics,'s Downside Deviation of 3.92, mean deviation of 3.02, and Risk Adjusted Performance of 0.1069 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Beta Bionics, holds a performance score of 16. The firm shows a Beta (market volatility) of 2.19, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Beta Bionics, will likely underperform. Please check Beta Bionics,'s potential upside, as well as the relationship between the accumulation distribution and price action indicator , to make a quick decision on whether Beta Bionics,'s price patterns will revert.
Auto-correlation | 0.76 |
Good predictability
Beta Bionics, Common has good predictability. Overlapping area represents the amount of predictability between Beta Bionics, time series from 1st of July 2025 to 29th of September 2025 and 29th of September 2025 to 28th of December 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Beta Bionics, Common price movement. The serial correlation of 0.76 indicates that around 76.0% of current Beta Bionics, price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.76 | |
| Spearman Rank Test | 0.86 | |
| Residual Average | 0.0 | |
| Price Variance | 15.44 |
Beta Bionics, Common lagged returns against current returns
Autocorrelation, which is Beta Bionics, stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Beta Bionics,'s stock expected returns. We can calculate the autocorrelation of Beta Bionics, returns to help us make a trade decision. For example, suppose you find that Beta Bionics, has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Beta Bionics, regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Beta Bionics, stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Beta Bionics, stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Beta Bionics, stock over time.
Current vs Lagged Prices |
| Timeline |
Beta Bionics, Lagged Returns
When evaluating Beta Bionics,'s market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Beta Bionics, stock have on its future price. Beta Bionics, autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Beta Bionics, autocorrelation shows the relationship between Beta Bionics, stock current value and its past values and can show if there is a momentum factor associated with investing in Beta Bionics, Common.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Beta Stock Analysis
When running Beta Bionics,'s price analysis, check to measure Beta Bionics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Beta Bionics, is operating at the current time. Most of Beta Bionics,'s value examination focuses on studying past and present price action to predict the probability of Beta Bionics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Beta Bionics,'s price. Additionally, you may evaluate how the addition of Beta Bionics, to your portfolios can decrease your overall portfolio volatility.